Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Rath

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2013
The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cellsThomas J Hayman, Amy Wahba, Barbara H Rath, et al.
Cancer Research|October 17, 2019
Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like CellsJoseph H McAbee, Barbara H Rath, Kristin Valdez, et al.
Nucleic Acids Research|December 12, 2019
53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapyIris Eke, Dali Zong, Molykutty J Aryankalayil, et al.
Journal of the American Chemical Society|October 26, 2017
Chasing Weak Forces: Hierarchically Assembled Helicates as a Probe for the Evaluation of the Energetics of Weak InteractionsDavid Van Craen, Wolfgang H Rath, Marina Huth, et al.
Stem Cell Reviews and Reports|February 27, 2010
Laser-assisted photoablation of human pluripotent stem cells from differentiating culturesStefanie Terstegge, Franziska Winter, Barbara H Rath, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 28, 2024
In Vivo Polymer Mechanochemistry with PolynucleotidesAman Ishaqat, Johannes Hahmann, Cheng Lin, et al.
Molecular Cancer Therapeutics|August 13, 2017
Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an ExampleIris Eke, Adeola Y Makinde, Molykutty J Aryankalayil, et al.
Annals of Neurology|August 10, 2010
Residual tumor cells are unique cellular targets in glioblastomaMartin Glas, Barbara H Rath, Matthias Simon, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2024
Structure and dynamics of a pentameric KCTD5/CUL3/Gβγ E3 ubiquitin ligase complexDuc Minh Nguyen, Deanna H Rath, Dominic Devost, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2013
The ATP-competitive mTOR inhibitor INK128 enhances in vitro and in vivo radiosensitivity of pancreatic carcinoma cellsThomas J Hayman, Amy Wahba, Barbara H Rath, et al.
Cancer Research|October 17, 2019
Radiation Drives the Evolution of Orthotopic Xenografts Initiated from Glioblastoma Stem-like CellsJoseph H McAbee, Barbara H Rath, Kristin Valdez, et al.
Nucleic Acids Research|December 12, 2019
53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapyIris Eke, Dali Zong, Molykutty J Aryankalayil, et al.
Journal of the American Chemical Society|October 26, 2017
Chasing Weak Forces: Hierarchically Assembled Helicates as a Probe for the Evaluation of the Energetics of Weak InteractionsDavid Van Craen, Wolfgang H Rath, Marina Huth, et al.
Stem Cell Reviews and Reports|February 27, 2010
Laser-assisted photoablation of human pluripotent stem cells from differentiating culturesStefanie Terstegge, Franziska Winter, Barbara H Rath, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 28, 2024
In Vivo Polymer Mechanochemistry with PolynucleotidesAman Ishaqat, Johannes Hahmann, Cheng Lin, et al.
Molecular Cancer Therapeutics|August 13, 2017
Exploiting Radiation-Induced Signaling to Increase the Susceptibility of Resistant Cancer Cells to Targeted Drugs: AKT and mTOR Inhibitors as an ExampleIris Eke, Adeola Y Makinde, Molykutty J Aryankalayil, et al.
Annals of Neurology|August 10, 2010
Residual tumor cells are unique cellular targets in glioblastomaMartin Glas, Barbara H Rath, Matthias Simon, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 16, 2024
Structure and dynamics of a pentameric KCTD5/CUL3/Gβγ E3 ubiquitin ligase complexDuc Minh Nguyen, Deanna H Rath, Dominic Devost, et al.
Pageof 4